Credit Suisse Ag Beam Therapeutics Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 100,544 shares of BEAM stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,544

Previous 110,833 9.28%

Holding current value

$2.92 Million

Previous $3.02 Million 10.11%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$23.46 - $45.07 $241,379 - $463,725	-10,289 Reduced 9.28%	100,544 $3.32 Million
Q4 2023 Feb 08, 2024	SELL	$17.69 - $30.76 $242,954 - $422,457	-13,734 Reduced 11.03%	110,833 $3.02 Million
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $656,291 - $925,824	28,522 Added 29.7%	124,567 $3 Million
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $526,997 - $646,884	17,974 Added 23.02%	96,045 $3.07 Million
Q1 2023 May 10, 2023	BUY	$30.15 - $48.79 $114,720 - $185,645	3,805 Added 5.12%	78,071 $2.39 Million
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $602,298 - $846,136	16,398 Added 28.34%	74,266 $2.9 Million
Q3 2022 Nov 10, 2022	BUY	$39.79 - $70.31 $148,217 - $261,904	3,725 Added 6.88%	57,868 $2.76 Million
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $266,321 - $556,188	8,919 Added 19.72%	54,143 $2.1 Million
Q1 2022 May 16, 2022	SELL	$53.73 - $82.16 $491,575 - $751,681	-9,149 Reduced 16.83%	45,224 $2.59 Million
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $9.9 Million - $14.4 Million	-145,610 Reduced 72.81%	54,373 $4.33 Million
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $14.4 Million - $22.8 Million	171,014 Added 590.33%	199,983 $17.4 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $331,372 - $665,173	5,168 Added 21.71%	28,969 $3.73 Million
Q1 2021 May 14, 2021	SELL	$71.28 - $120.75 $2.49 Million - $4.22 Million	-34,927 Reduced 59.47%	23,801 $1.91 Million
Q4 2020 Feb 12, 2021	BUY	$22.24 - $95.63 $1.11 Million - $4.77 Million	49,907 Added 565.77%	58,728 $4.79 Million
Q3 2020 Nov 13, 2020	BUY	$19.0 - $30.57 $167,599 - $269,657	8,821 New	8,821 $218,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account